HIV & Hepatitis C Co-Infection

This One-day training is for health and human service providers who work with people living with HIV and who need updated information about HIV/HCV co-infection in order to provide effective services to their clients. More than 25% of people living with HIV in the United States are co-infected with the hepatitis C virus (HCV). Among people who acquired HIV as a result of injection drug use, the rates of HIV/HCV co-infection may be as high as 90%. HCV screening is recommended for all persons living with HIV.

As a result of this training, participants will be able to:

• Recall basic information about the liver and hepatitis C, including transmission, prevention, course of illness, screening and treatment;
• Counsel their HIV positive client about the importance of knowing their HCV status;
• Describe how co-infection with HIV and HCV affects the progression of each disease;
• Recall current trends and improvements in treatment for people who are co-infected with HIV and HCV; and
• List at least three additional service needs of people with HIV who are also co-infected with HCV.

Prerequisite: Although there is no prerequisite for this training, it is strongly recommended that participants have previous training in HIV/AIDS.

Audience: All health and human service providers.

To register, visit www.hivtrainingny.org.